CC enters the week with a rare alignment of signals: the stock is down nearly 8% and options traders have abruptly shifted to their most defensive posture in months.
The sharpest signal this week is in options. The put/call ratio jumped to 0.33 on Tuesday — more than three standard deviations above its 20-day average of 0.23. That's the most defensive reading in recent memory, well clear of the prior norm and suggesting a genuine rotation toward downside protection rather than routine hedging. The stock closed at $19.96 on Tuesday, down 7% on the day and off nearly 8% for the week — the largest weekly loss in recent months. The selloff has been broad across the TiO2 peer group: TROX fell 17% on the week and OLN dropped 15%, so CC is not the only name under pressure, but it is among the harder hit.
Short positioning tells a building story. Short interest reached 6.4% of the free float — up roughly 10.5% over the past month and now running at a new recent high. The week-on-week increase was modest at under 2%, but the trend has been consistently upward since late May, when SI sat closer to 5.6% of float. Borrow costs have risen sharply, up 40% on the week to 0.54% — still low in absolute terms, but the direction of travel is notable given the simultaneous stock decline. Availability, by contrast, remains extremely loose at roughly 1,587% — meaning there are far more shares available to lend than are currently borrowed — so there is no squeeze pressure in the lending pool and no structural impediment to shorts adding further.
The Street has been cautiously constructive on CC, though the most recent analyst moves are now more than a month old. JP Morgan and Morgan Stanley both lifted targets in May — to $22 and $21 respectively — while maintaining neutral ratings, a pattern that reflects acknowledgement of the recovery narrative without conviction to upgrade. The bulls, led by UBS and Truist at $30, cite pricing power and the "Pathway to Thrive" cost programme expected to deliver over $250m in savings through 2027. Bears point to regulatory pressure on HFC/HFO demand, new TiO2 capacity additions, and weak European and Asian end-markets as threats to the margin recovery timeline. The consensus mean target of $26.33 implies roughly 32% upside from current levels — a gap that has widened materially this week as the stock fell toward $20.
Factor scores add nuance to the picture. EPS surprise ranks in the 96th percentile — CC has a strong recent track record of beating estimates. EPS momentum over the past 30 days is also healthy, ranking in the 77th percentile. But the short score rank sits at just the 22nd percentile and the ORTEX short score itself has edged higher every day this week, reaching 43.7 — a 10-day high — reflecting the steady accumulation of bearish positioning signals even as the absolute short interest level remains moderate.
Earnings history provides important context here. The most recent print on May 6 produced a one-day drop of nearly 20%. The prior release triggered a 13% fall. CC has now posted back-to-back significant earnings-day declines, with five-day losses of roughly 9-10% after each. The next scheduled print is August 5. That event is now the focal point: whether the bear case on HFO/TiO2 margins is materialising faster than the cost programme can offset it, and whether options traders buying puts this week are positioning for that risk or reacting to the broader chemicals sector rout.
See the live data behind this article on ORTEX.
Open CC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
